Loading...
menu
Search
Features
Markets
News
Resources
Pricing
Home
ETF
ACON
ACON
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
Latest ACON ETF News Today | Earnings, Events & Price Alerts
ACON News
Aclarion Releases 2026 Shareholder Letter Highlighting Key Milestones
Feb 05 2026
Newsfilter
Aclarion CEO Outlines 2026 Execution Plan Focused on Reimbursement and Adoption
Feb 04 2026
stocktwits
Aclarion Expands Nociscan Availability in Greater Los Angeles
Feb 03 2026
Newsfilter
Aclarion, Inc. Closes $10.4 Million Financing, Extends Cash Runway to 2028
Jan 13 2026
Benzinga
Aclarion Closes $10.4 Million Financing, Extends Cash Runway to 2028
Jan 13 2026
Globenewswire
U.S. Nonfarm Payrolls Increase by 50,000, Unemployment Rate Drops to 4.4%
Jan 09 2026
Benzinga
WD-40 Co Reports Q1 Earnings Miss, Shares Drop 9.1%
Jan 09 2026
Benzinga
Tilray Brands Reports Q2 Earnings Beat, Shares Surge 7.3%
Jan 09 2026
Benzinga
Aclarion (ACON) Shares Surge 50% Following 2025 Business Update and 2026 Outlook
Jan 08 2026
NASDAQ.COM
Aclarion Reports 69% Year-over-Year Scan Volume Growth Entering 2026 with Strong Financial Position
Jan 08 2026
Benzinga
Aclarion (ACON) Reports 69% Year-over-Year Growth in Nociscan Scan Volumes
Jan 08 2026
NASDAQ.COM
Aclarion Reports 114% Year-over-Year Growth in Nociscan Scan Volumes for Q4 2025
Jan 08 2026
Globenewswire
Aclarion Initiates CLARITY Trial with Four Centers Enrolling Patients
Jan 06 2026
Globenewswire
Nvidia Set to Surge by 72%? Check Out 10 Leading Analyst Predictions for Thursday
Nov 20 2025
Benzinga
Ascendiant Capital Reiterates Buy Rating on Aclarion, Increases Price Target to $23
Nov 20 2025
Benzinga
Aclarion Names Dan Isherwood as UK Commercial Director to Enhance Adoption and Expand Market Reach
Nov 05 2025
Newsfilter
Show More News
